Tags: new | diabetes | drug | Type | 2 | empagliflozin | late-stage

New Diabetes Drug Found Effective

Monday, 07 Jan 2013 12:00 PM

Eli Lilly and Co and Boehringer Ingelheim said on Monday that a treatment for Type 2 diabetes, empagliflozin, had been shown to work in four late-stage trials.
The drug aims to reduce blood glucose levels in adults with Type 2 diabetes, the most common form of diabetes in which the body either does not produce enough insulin or the cells ignore the insulin.
About 371 million people worldwide are estimated to have diabetes.
The companies said they expect to file for regulatory review of the drug in the United States, Europe and Japan in 2013 and will present detailed data from the trials this year and next.
The companies said that among adverse reactions, genital infections occurred more often with the treatment than with the placebo.
Boehringer and Lilly are collaborating on several diabetes drugs. On Monday, they said only Lilly would continue with collaboration on another one of the treatments, known as LY2605541.

© HealthDay

1Like our page
2Share
Diabetes
A new drug to treat Type 2 diabetes called empagliflozin has been effective in late-stage trials.
new,diabetes,drug,Type,2,empagliflozin,late-stage,trials
154
2013-00-07
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved